US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 2.680
  • +0.200+8.06%
Close Dec 11 16:00 ET
  • 2.610
  • -0.070-2.61%
Post 20:01 ET
331.07MMarket Cap-4.47P/E (TTM)

Mersana Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
63.65%12.6M
-78.48%2.29M
18.50%9.25M
38.65%36.86M
-27.14%10.7M
38.13%7.7M
148.69%10.65M
283.20%7.8M
61,716.28%26.58M
133,427.27%14.69M
Operating revenue
63.65%12.6M
-78.48%2.29M
18.50%9.25M
38.65%36.86M
-27.14%10.7M
38.13%7.7M
148.69%10.65M
283.20%7.8M
61,716.28%26.58M
133,427.27%14.69M
Cost of revenue
Gross profit
Operating expense
-43.20%24.67M
-58.68%27.75M
-53.90%30.25M
-9.78%207.81M
-47.73%31.63M
-33.41%43.43M
19.85%67.16M
35.02%65.6M
36.38%230.35M
25.96%60.51M
Selling and administrative expenses
-23.50%9.86M
-42.25%10.5M
-36.93%11.56M
4.53%59.54M
-31.55%10.13M
-11.52%12.89M
22.86%18.19M
43.39%18.33M
54.42%56.96M
38.70%14.81M
-General and administrative expense
-23.50%9.86M
-42.25%10.5M
-36.93%11.56M
4.53%59.54M
-31.55%10.13M
-11.52%12.89M
22.86%18.19M
43.39%18.33M
54.42%56.96M
38.70%14.81M
Research and development costs
-51.51%14.8M
-64.78%17.25M
-60.47%18.69M
-14.49%148.27M
-52.97%21.5M
-39.71%30.53M
18.77%48.97M
32.03%47.28M
31.34%173.39M
22.32%45.71M
Operating profit
66.22%-12.07M
54.95%-25.46M
63.67%-21M
16.10%-170.96M
54.33%-20.93M
40.09%-35.73M
-9.18%-56.5M
-24.16%-57.8M
-20.67%-203.77M
4.59%-45.83M
Net non-operating interest income expense
-56.85%986K
-45.90%1.19M
3.48%1.7M
1,897.75%8M
108.76%1.88M
1,428.49%2.29M
567.80%2.19M
332.01%1.64M
62.98%-445K
194.75%902K
Non-operating interest income
-40.28%1.97M
-32.59%2.17M
2.90%2.7M
318.77%12.07M
57.07%2.93M
366.38%3.3M
1,006.19%3.22M
14,461.11%2.62M
4,335.38%2.88M
6,334.48%1.87M
Non-operating interest expense
-3.05%986K
-4.10%983K
1.93%1M
22.39%4.07M
8.71%1.05M
15.57%1.02M
34.87%1.03M
35.77%983K
162.67%3.33M
-1.73%964K
Other net income (expense)
-8.71M
-499K
-8.21M
Special income (charges)
--0
----
----
---8.71M
---499K
---8.21M
----
----
--0
--0
-Less：Restructuring and merger&acquisition
--0
----
----
--8.71M
--499K
--8.21M
----
----
--0
--0
Income before tax
73.39%-11.08M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
Income tax
418K
0
Net income
72.39%-11.5M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
Net income continuous Operations
72.39%-11.5M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
Minority interest income
Net income attributable to the parent company
72.39%-11.5M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
72.39%-11.5M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
Basic earnings per share
74.29%-0.09
57.45%-0.2
69.23%-0.16
32.11%-1.48
63.64%-0.16
42.62%-0.35
14.55%-0.47
11.86%-0.52
9.54%-2.18
35.29%-0.44
Diluted earnings per share
74.29%-0.09
57.45%-0.2
69.23%-0.16
32.11%-1.48
63.64%-0.16
42.62%-0.35
14.55%-0.47
11.86%-0.52
9.54%-2.18
35.29%-0.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 63.65%12.6M-78.48%2.29M18.50%9.25M38.65%36.86M-27.14%10.7M38.13%7.7M148.69%10.65M283.20%7.8M61,716.28%26.58M133,427.27%14.69M
Operating revenue 63.65%12.6M-78.48%2.29M18.50%9.25M38.65%36.86M-27.14%10.7M38.13%7.7M148.69%10.65M283.20%7.8M61,716.28%26.58M133,427.27%14.69M
Cost of revenue
Gross profit
Operating expense -43.20%24.67M-58.68%27.75M-53.90%30.25M-9.78%207.81M-47.73%31.63M-33.41%43.43M19.85%67.16M35.02%65.6M36.38%230.35M25.96%60.51M
Selling and administrative expenses -23.50%9.86M-42.25%10.5M-36.93%11.56M4.53%59.54M-31.55%10.13M-11.52%12.89M22.86%18.19M43.39%18.33M54.42%56.96M38.70%14.81M
-General and administrative expense -23.50%9.86M-42.25%10.5M-36.93%11.56M4.53%59.54M-31.55%10.13M-11.52%12.89M22.86%18.19M43.39%18.33M54.42%56.96M38.70%14.81M
Research and development costs -51.51%14.8M-64.78%17.25M-60.47%18.69M-14.49%148.27M-52.97%21.5M-39.71%30.53M18.77%48.97M32.03%47.28M31.34%173.39M22.32%45.71M
Operating profit 66.22%-12.07M54.95%-25.46M63.67%-21M16.10%-170.96M54.33%-20.93M40.09%-35.73M-9.18%-56.5M-24.16%-57.8M-20.67%-203.77M4.59%-45.83M
Net non-operating interest income expense -56.85%986K-45.90%1.19M3.48%1.7M1,897.75%8M108.76%1.88M1,428.49%2.29M567.80%2.19M332.01%1.64M62.98%-445K194.75%902K
Non-operating interest income -40.28%1.97M-32.59%2.17M2.90%2.7M318.77%12.07M57.07%2.93M366.38%3.3M1,006.19%3.22M14,461.11%2.62M4,335.38%2.88M6,334.48%1.87M
Non-operating interest expense -3.05%986K-4.10%983K1.93%1M22.39%4.07M8.71%1.05M15.57%1.02M34.87%1.03M35.77%983K162.67%3.33M-1.73%964K
Other net income (expense) -8.71M-499K-8.21M
Special income (charges) --0-----------8.71M---499K---8.21M----------0--0
-Less：Restructuring and merger&acquisition --0----------8.71M--499K--8.21M----------0--0
Income before tax 73.39%-11.08M55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M
Income tax 418K0
Net income 72.39%-11.5M55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M
Net income continuous Operations 72.39%-11.5M55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M
Minority interest income
Net income attributable to the parent company 72.39%-11.5M55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 72.39%-11.5M55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M
Basic earnings per share 74.29%-0.0957.45%-0.269.23%-0.1632.11%-1.4863.64%-0.1642.62%-0.3514.55%-0.4711.86%-0.529.54%-2.1835.29%-0.44
Diluted earnings per share 74.29%-0.0957.45%-0.269.23%-0.1632.11%-1.4863.64%-0.1642.62%-0.3514.55%-0.4711.86%-0.529.54%-2.1835.29%-0.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+9.03%
Tesla
TSLA
+5.93%
Alphabet-A
GOOGL
+5.52%
Alphabet-C
GOOG
+5.46%
Coinbase
COIN
+3.77%

Unlock the Full List